DNA methylation regulates adenosine A2A receptor cell surface expression levels

Journal of Neurochemistry

Volumn 112, Issue 5, 2010, Pages 1273-1285

  Buira, Sandra P ^a   Albasanz, José Luis ^b   Dentesano, Guido ^a   Moreno, Jesús ^a   Martín, Mairena ^b   Ferrer, Isidre ^a,c,d   Barrachina, Marta ^a,d  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

5 azacytidine; Adenosine A2A receptor; CpG island; DNA methylation; S adenosyl l methionine

Indexed keywords

ADENOSINE A2A RECEPTOR; AZACITIDINE; DNA; S ADENOSYLMETHIONINE;

5' UNTRANSLATED REGION; ARTICLE; BIOINFORMATICS; CELL SURFACE; CHROMATIN IMMUNOPRECIPITATION; CPG ISLAND; DNA METHYLATION; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RADIOASSAY; REGULATORY MECHANISM; RNA PURIFICATION;

AZACITIDINE; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HELA CELLS; HUMANS; IMMUNOPRECIPITATION; METHYL-CPG-BINDING PROTEIN 2; NEUROBLASTOMA; PROTEIN BINDING; RADIOLIGAND ASSAY; RECEPTOR, ADENOSINE A2A; RECEPTORS, CELL SURFACE; RNA, MESSENGER; S-ADENOSYLMETHIONINE; TIME FACTORS; TRIAZINES; TRIAZOLES; TRITIUM;

EID: 75949099828     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06538.x     Document Type: Article

References (47)

1. Albasanz J. L., Rodríguez A., Ferrer I. Martín M. (2006) Adenosine A2A receptors are up-regulated in Pick's disease frontal cortex. Brain Pathol. 16, 249 255.
2. Ballestar E. Wolffe A. P. (2001) Methyl-CpG-binding proteins. Targeting specific gene repression. Eur. J. Biochem. 268, 1 6.
3. Bara-Jimenez W., Sherzai A., Dimitrova T., Favit A., Bibbiani F., Gillespie M., Morris M. J., Mouradian M. M. Chase T. N. (2003) Adenosine A(2A) receptor antagonist treatment of Parkinson's disease. Neurology 61, 293 296.
4. Barrachina M. Ferrer I. (2009) DNA methylation of Alzheimer disease and tauopathy-related genes in post-mortem brain. J. Neuropathol. Exp. Neurol. 68, 880 891.
5. Calon F., Dridi M., Hornykiewicz O., Bédard P. J., Rajput A. H. Di Paolo T. (2004) Increased adenosine A2A receptors in the brain of Parkinson's disease patients with dyskinesias. Brain 127, 1075 1084.
6. Chen J. F., Huang Z., Ma J., Zhu J., Moratalla R., Standaert D., Moskowitz M. A., Fink J. S. Schwarzschild M. A. (1999) A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice. J. Neurosci. 19, 9192 9200.
7. Chiang M. C., Lee Y. C., Huang C. L. Chern Y. (2005) cAMP-response element-binding protein contributes to suppression of the A2A adenosine receptor promoter by mutant Huntingtin with expanded polyglutamine residues. J. Biol. Chem. 280, 14331 14340.
8. Constantinides P. G., Jones P. A. Gevers W. (1977) Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment. Nature 267, 364 366.
9. Costello J. F., Frühwald M. C., Smiraglia D. J. et al. (2000) Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet. 24, 132 138.
10. Cunha R. A., Ferré S., Vaugeois J. M. Chen J. F. (2008) Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. Curr. Pharm. Des. 14, 1512 1524.
11. Deckert J., Brenner M., Durany N. et al. (2003) Up-regulation of striatal adenosine A(2A) receptors in schizophrenia. Neuroreport 14, 313 316.
12. Ehrich M., Nelson M. R., Stanssens P., Zabeau M., Liloglou T., Xinarianos G., Cantor C. R., Field J. K. van den Boom D. (2005) Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry. Proc. Natl Acad. Sci. USA 102, 15785 15790.
13. Ferré S. (1997) Adenosine-dopamine interactions in the ventral striatum. Implications for the treatment of schizophrenia. Psychopharmacology (Berl) 133, 107 120.
14. Ferre S., von Euler G., Johansson B., Fredholm B. B. Fuxe K. (1991) Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes. Proc. Natl Acad. Sci. USA 88, 7238 7241.
15. Flotho C., Claus R., Batz C., Schneider M., Sandrock I., Ihde S., Plass C., Niemeyer C. M. Lübbert M. (2009) The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells. Leukemia 23, 1019 1028.
16. Fredholm B. B., IJzerman A. P., Jacobson K. A., Klotz K. N. Linden J. (2001) International Union of PharmacologyXXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53, 527 552.
17. Fredholm B. B., Chen J. F., Cunha R. A., Svenningsson P. Vaugeois J. M. (2005a) Adenosine and brain function. Int. Rev. Neurobiol. 63, 191 270.
18. Fredholm B. B., Chen J. F., Masino S. A. Vaugeois J. M. (2005b) Actions of adenosine at its receptors in the CNS: insights from knockouts and drugs. Annu. Rev. Pharmacol. Toxicol. 45, 385 412.
19. Fuso A., Seminara L., Cavallaro R. A., D'Anselmi F. Scarpa S. (2005) S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol. Cell. Neurosci. 28, 195 204.
20. Fuso A., Nicolia V., Cavallaro R. A., Ricceri L., D'Anselmi F., Coluccia P., Calamandrei G. Scarpa S. (2008) B-vitamin deprivation induces hyperhomocysteinemia and brain S-adenosylhomocysteine, depletes brain S-adenosylmethionine, and enhances PS1 and BACE expression and amyloid-beta deposition in mice. Mol. Cell. Neurosci. 37, 731 746.
21. Herman J. G. Baylin S. B. (2003) Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349, 2042 2054.
22. Illingworth R. S. Bird A. P. (2009) CpG islands -"A rough guide". FEBS Lett. 583, 1713 1720.
23. Jones P. A. (1999) The DNA methylation paradox. Trends Genet. 15, 34 37.
24. Jones P. A., Smith R. A. Stone T. W. (1998) Protection against hippocampal kainate excitotoxicity by intracerebral administration of an adenosine A2A receptor antagonist. Brain Res. 800, 328 335.
25. Kreth S., Ledderose C., Kaufmann I., Groeger G. Thiel M. (2008) Differential expression of 5′-UTR splice variants of the adenosine A2A receptor gene in human granulocytes: identification, characterization, and functional impact on activation. FASEB J. 22, 3276 3286.
26. Le F., Townsend-Nicholson A., Baker E., Sutherland G. R. Schofield P. R. (1996) Characterization and chromosomal localization of the human A2a adenosine receptor gene: ADORA2A. Biochem. Biophys. Res. Commun. 223, 461 467.
27. LeWitt P. A., Guttman M., Tetrud J. W., Tuite P. J., Mori A., Chaikin P. Sussman N. M., 6002-US-005 Study Group (2008) Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005). Ann. Neurol. 63, 295 302.
28. Lopez-Serra L. Esteller M. (2008) Proteins that bind methylated DNA and human cancer: reading the wrong words. Br. J. Cancer 98, 1881 1885.
29. Lowry O. H., Rosebrough N. J., Farr A. L. Randall D. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265 275.
30. Lukashev D., Ohta A., Apasov S., Chen J. F. Sitkovsky M. (2004) Cutting edge: physiologic attenuation of proinflammatory transcription by the Gs protein-coupled A2A adenosine receptor in vivo. J. Immunol. 173, 21 24.
31. MacCollin M., Peterfreund R., MacDonald M., Fink J. S. Gusella J. (1994) Mapping of a human A2a adenosine receptor (ADORA2A) to chromosome 22. Genomics 20, 332 333. (Pubitemid 24108424)
32. Murphree L. J., Sullivan G. W., Marshall M. A. Linden J. (2005) Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction. Biochem. J. 391, 575 580.
33. Ohta A. Sitkovsky M. (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414, 916 920.
34. Ohta A., Gorelik E., Prasad S. J. et al. (2006) A2A adenosine receptor protects tumors from antitumor T cells. Proc. Natl Acad. Sci. USA 103, 13132 13137.
35. Perez-Buira S., Barrachina M., Rodriguez A., Albasanz J. L., Martín M. Ferrer I. (2007) Expression levels of adenosine receptors in hippocampus and frontal cortex in argyrophilic grain disease. Neurosci. Lett. 423, 194 199.
36. Peterfreund R. A., MacCollin M., Gusella J. Fink J. S. (1996) Characterization and expression of the human A2a adenosine receptor gene. J. Neurochem. 66, 362 368.
37. Peterfreund R. A., Gies E. K. Fink J. S. (1997) Protein kinase C regulates adenosine A2a receptor mRNA expression in SH-SY5Y cells. Eur. J. Pharmacol. 336, 71 80.
38. Popoli P., Pintor A., Domenici M. R. et al. (2002) Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum. J. Neurosci. 22, 1967 1975.
39. Ruiz M. A., Escriche M., Lluis C., Franco R., Martín M., Andrés A. Ros M. (2000) Adenosine A(1) receptor in cultured neurons from rat cerebral cortex: colocalization with adenosine deaminase. J. Neurochem. 75, 656 664.
40. Scarpa S., Fuso A., D'Anselmi F. Cavallaro R. A. (2003) Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease? FEBS Lett. 541, 145 148.
41. Schwarzschild M. A., Agnati L., Fuxe K., Chen J. F. Morelli M. (2006) Targeting adenosine A2A receptors in Parkinson's disease. Trends Neurosci. 29, 647 654.
42. Simola N., Morelli M. Pinna A. (2008) Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions. Curr. Pharm. Des. 14, 1475 1489.
43. St. Hilaire C., Carroll S. H., Chen H. Ravid K. (2009) Mechanisms of induction of adenosine receptor genes and its functional significance. J. Cell. Physiol. 218, 35 44.
44. Sunahori K., Juang Y. T. Tsokos G. C. (2009) Methylation status of CpG islands flanking a cAMP response element motif on the protein phosphatase 2Ac alpha promoter determines CREB binding and activity. J. Immunol. 182, 1500 1508.
45. Weber M., Hellmann I., Stadler M. B., Ramos L., Pääbo S., Rebhan M. Schübeler D. (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat. Genet. 39, 457 466.
46. Yossifoff M., Kisliouk T. Meiri N. (2008) Dynamic changes in DNA methylation during thermal control establishment affect CREB binding to the brain-derived neurotrophic factor promoter. Eur. J. Neurosci. 28, 2267 2277.
47. Yu L., Frith M. C., Suzuki Y. et al. (2004) Characterization of genomic organization of the adenosine A2A receptor gene by molecular and bioinformatics analyses. Brain Res. 1000, 156 173.